The latest Life Healthcare trading statement shows the hospital group expects higher normalised earnings for the year to end-September, although some measures are under pressure. Normalised EPS from continuing operations is expected to rise 6%-11% to 106.3c-111.3c, from 100.3c a year earlier.
However, HEPS from continuing operations is expected to fall 1%-6% to 100.7c-106c. That compares with a pro forma figure of 107.1c for the previous year.
Continue reading with a Health Matters subscription
Subscribers read every article in full, receive the daily briefing and have access to the complete archive.
Not ready to subscribe? Get Health Matters Weekly free: the week’s top healthcare headlines every Friday.